Skip to main content

TWINNING ON DNA-BASED CANCER VACCINES

Objective

The objective of this Twinning project is to significantly strengthen the research in Riga Stradins University (RSU; Latvia) in the smart specialization area of Latvia “bio-medicine, medical technologies, and biotechnologies” with application to immunotherapy of cancer through building an up-rising connections with two internationally leading research institutions, Institute of Microbiology, Tumor and Cell Biology, Karolinska Institutet (Sweden) and the Department of General Biophysics, University of Lodz (Poland). Both represent centers of excellence in the design, testing and clinical applications of a wide class of immunotherapeuticals, with focus on technologies exploiting naked nucleic acids.

Call for proposal

H2020-TWINN-2015
See other projects for this call

Funding Scheme

CSA - Coordination and support action

Coordinator

RIGAS STRADINA UNIVERSITATE
Address
Dzirciema Street 16
1007 Riga
Latvia
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 357 575

Participants (3)

KAROLINSKA INSTITUTET
Sweden
EU contribution
€ 327 295
Address
Nobels Vag 5
17177 Stockholm
Activity type
Higher or Secondary Education Establishments
UNIWERSYTET LODZKI
Poland
EU contribution
€ 165 855
Address
Ul Prezydenta Gabriela Narutowicza 68
90 136 Lodz
Activity type
Higher or Secondary Education Establishments
R.E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY ONCOLOGY AND RADIOBIOLOGY OF NATIONAL ACADEMY OF SCIENCES OF UKRAINE
Ukraine
EU contribution
€ 148 750
Address
Vasylkivska Str 45
03022 Kyiv
Activity type
Research Organisations